Where it all began: why we wrote ‘The Site Factor’
April 8, 2026 | Clinical Sites, Participant engagement, Site Teams, clinical trials
Discover the story behind ‘The Site Factor’ and how understanding site teams’ experiences can transform clinical trials for participants and researchers alike.
When we published ‘The Participation Equation’ last year, we set out to better understand how participants experience clinical studies and what shapes their engagement. What quickly became clear was the central role of the study team. Across different trials and settings, participant experience was moulded by the quality of that relationship.
As studies become more digital and decentralised, participants continue to tell us that human connection really matters to them.
That insight led us to a natural next question: if site teams play such a defining role in participant experience, how well do we understand their experience?
Why this research, and why now?
In 2025, we saw sponsors looking for ways to support sites with the increasing strain they are under. Recruitment is tougher, protocols are more demanding, and expectations continue to rise. Sponsors recognise that they must get site support right, but they are often unsure about how or where to start, or what could make the biggest difference in practice.
This was the catalyst for ‘The Site Factor’.
Before adding to the conversation, we wanted to better understand the reality on the ground. How are protocols translated into daily work? Where do challenges show up in interactions with participants? And what support do site teams need to deliver a trial experience that feels good for everyone involved?
We spoke with more than 100 site team members across nine countries, listening closely to where things feel hard, where systems don’t quite join up, and where there’s genuine opportunity to do better. We heard about the importance of alignment and its impact on participant experience, as well as the sponsor cost burden when those things are missing.
Bringing these perspectives together is an important step. It gives us a clear picture of the current landscape and a solid foundation to build on.
A springboard
This report sits alongside ‘The Participation Equation’, adding an important second perspective.
By putting ourselves in the shoes of site staff, we are sparking conversations and practical action towards the shared goal of making trials work better for everyone involved. Not through quick fixes, but through thoughtful, practical real-world solutions.
This is the work we care deeply about — turning insight into action, and data into meaningful change. Because when we listen to what truly matters — to participants and site teams alike — we can design research that works in practice, not just on paper.
This content was provided by Cuttsy + Cuttsy
Company Details
Latest Content from Cuttsy + Cuttsy
Empowering patients through more accessible clinical trial information
Senior Medical Writer, Scott Palmer explores the challenges and solutions in enhancing patient engagement in clinical trials, from the pivotal role of healthcare professionals, to the importance of user-friendly trial...
New report now available: Integrating ‘patient first’ into medicine development
A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...
The digital prescription – enhancing the patient experience with technology
We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.
Compliance — a driving force for influencing public perceptions of the pharma industry?
How does compliance play into public perceptions of pharma and why is it important for improving public opinion?
Another year, another B!
Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.
Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.
Clinical trial considerations: Why supporting HCPs matters…
When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.
Clinical trial considerations: Why diversity matters…
Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...
Clinical trial considerations: Why digital matters…
Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.
Clinical trials explained: Why imagery matters…
Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...